PERSPECTA

News from every angle

← Back to headlines

AstraZeneca Reports Positive Interim Results from I CAN Phase III Trial

AstraZeneca PLC announced positive findings from a prespecified interim analysis of its I CAN Phase III clinical trial, indicating promising results for the studied treatment.

27 Apr, 06:05 — 27 Apr, 06:05
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual127d ago

AstraZeneca PLC (AZN) Announces Positive Results From a Prespecified Interim Analysis of the I CAN Phase III Trial

Read full article →

Related Stories

IAEA Secures 73 Tons of Syrian Uranium From Assad Era

2h ago

Scientists Report Potential Breakthrough in Search for Dark Matter

3h ago

UN Warns of Severe Glacial Flood Risks Across the Himalayas

9h ago

German Weather Service Confirms Hottest Summer on Record

1d ago

AstraZeneca Reports Positive Interim Results from I CAN Phase III Trial | Perspecta News